ERCC4 and breast cancer: Among them we can highlight inhibitors of the NS3 (Nonstructural protein 3) helicase of Dengue virus [33]; inhibitors of RAC1 (Ras-related C3 botulinum toxin substrate 1) in highly aggressive breast cancer lines [34]; and inhibitors of human XPF (Xeroderma pigmentosum, complementation group F) endonuclease for combination treatment with chemotherapy [35].